Evidence map›Paper›PMID 30062417›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2018

In Vivo Rescue Assay of RhoA-Deficient Hematopoietic Stem and Progenitor Cells.

Xiongwei Cai, Xuan Zhou, Yi Zheng

Open access · greenAbstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Xiongwei CaiCancer and Blood Diseases Institute, Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH, USA.
Xuan ZhouCancer and Blood Diseases Institute, Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH, USA.
Yi ZhengCancer and Blood Diseases Institute, Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH, USA. yi.zheng@cchmc.org.
University of Cincinnati · USCincinnati Children's Hospital Medical Center · US

Funding

Cdc42, hematopoietic stem cell polarity, and cell fateR01DK104814 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI ZHENG, YI · 2016 to 2019
$2.0M
Targeting Cdc42 for bone marrow transplant therapiesR01CA193350 · NCI · CINCINNATI CHILDRENS HOSP MED CTR · PI ZHENG, YI · 2015 to 2019
$1.8M
NCI NIH HHS R01 CA193350NIDDK NIH HHS R01 DK104814
6 · The paper itself

Abstract

RhoA is a founding member of Rho GTPase family and is a well-recognized regulator of actin cytoskeleton dynamics. Signal pathways transduced by RhoA are involved in cell migration, polarity, morphogenesis, proliferation, survival, and cell fate decision. Conditional gene targeting of Rhoa in murine blood system induces acute hematopoietic failure due to the loss of multilineage hematopoietic progenitor cells (HPC) caused by a cytokinesis defect and necrosis. Here we describe a method to conditionally induce Rhoa gene knockout in murine blood cells and a rescue by exogenous RhoA expression with lentivirus in HPCs, an approach that has general applicability in studying in vivo function of Rho GTPases and their regulators/effectors by gene targeting.

Indexed as

Lentivirusrho GTP-Binding ProteinsAnimalsGene Knockout TechniquesHEK293 CellsHematopoietic Stem CellsHumansMiceNIH 3T3 CellsrhoA GTP-Binding ProteinTransduction, GeneticrhoA GTP-Binding ProteinRhoA protein, mouserho GTP-Binding ProteinsCell fateGene targetingHematopoiesisRescueRhoATransplantationViral transduction

Identifiers

PMID30062417
PMCPMC6555551
OpenAlexW2886843748

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.